- Home
- VSTS vs RCKT Comparison
VSTS vs RCKT Comparison
Compare VSTS & RCKT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VSTS
- RCKT
- Stock Information
- Founded
- VSTS 1936
- RCKT 1999
- Country
- VSTS United States
- RCKT United States
- Employees
- VSTS N/A
- RCKT N/A
- Industry
- VSTS
- RCKT Biotechnology: Pharmaceutical Preparations
- Sector
- VSTS
- RCKT Health Care
- Exchange
- VSTS Nasdaq
- RCKT Nasdaq
- Market Cap
- VSTS 763.0M
- RCKT 264.0M
- IPO Year
- VSTS N/A
- RCKT N/A
- Fundamental
- Price
- VSTS $6.13
- RCKT $2.99
- Analyst Decision
- VSTS Hold
- RCKT Buy
- Analyst Count
- VSTS 4
- RCKT 13
- Target Price
- VSTS $11.75
- RCKT $18.50
- AVG Volume (30 Days)
- VSTS 3.0M
- RCKT 3.8M
- Earning Date
- VSTS 08-06-2025
- RCKT 08-04-2025
- Dividend Yield
- VSTS 1.71%
- RCKT N/A
- EPS Growth
- VSTS N/A
- RCKT N/A
- EPS
- VSTS N/A
- RCKT N/A
- Revenue
- VSTS $2,731,558,000.00
- RCKT N/A
- Revenue This Year
- VSTS N/A
- RCKT N/A
- Revenue Next Year
- VSTS $0.36
- RCKT N/A
- P/E Ratio
- VSTS N/A
- RCKT N/A
- Revenue Growth
- VSTS N/A
- RCKT N/A
- 52 Week Low
- VSTS $5.20
- RCKT $2.19
- 52 Week High
- VSTS $17.83
- RCKT $26.98
- Technical
- Relative Strength Index (RSI)
- VSTS 49.23
- RCKT 45.55
- Support Level
- VSTS $5.87
- RCKT $2.76
- Resistance Level
- VSTS $6.36
- RCKT $3.24
- Average True Range (ATR)
- VSTS 0.26
- RCKT 0.19
- MACD
- VSTS 0.06
- RCKT 0.17
- Stochastic Oscillator
- VSTS 71.25
- RCKT 74.85
About VSTS Vestis Corporation
Vestis Corp is a provider of uniform rentals and workplace supplies across the United States and Canada. It provides uniforms, mats, towels, linens, restroom supplies, first-aid supplies, safety products, and other workplace supplies. The Company serves customers ranging from small, family-owned operations with a single location to large corporations and national franchises with multiple locations. The company operates in the United States and Canada as reportable segments. The company earns the majority of its revenue from the United States.
About RCKT Rocket Pharmaceuticals Inc.
Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.